Four Cases of Suspected Levetiracetam-Induced Asymptomatic Rhabdomyolysis

被引:3
作者
Saito, Satoshi [1 ]
Iijima, Mutsumi [1 ]
Ikeguchi, Ryotaro [1 ]
Ishizuka, Kentaro [1 ]
Kitagawa, Kazuo [1 ]
机构
[1] Tokyo Womens Med Univ, Dept Neurol, Sch Med, Tokyo, Japan
关键词
epilepsy; serum creatine kinase; rhabdomyolysis; levetiracetam; antiepileptic drug; SERUM CREATINE-KINASE; SEIZURES;
D O I
10.7759/cureus.41666
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rhabdomyolysis is a known side effect of levetiracetam. In general, a patient with rhabdomyolysis complains of muscle pain and swelling. Herein, we report four cases of asymptomatic levetiracetam-induced rhabdomyolysis. In all the four cases, the seizures resolved after more than five days. The patients received continuous fluid replacement from the time they were admitted to our hospital. However, serum creatine kinase (CK) levels continued to rise without symptoms consistent with rhabdomyolysis. The serum CK level improved rapidly when levetiracetam was replaced with lacosamide. Because levetiracetam occasionally causes asymptomatic rhabdomyolysis, routine blood tests should be performed after its initiation.
引用
收藏
页数:6
相关论文
共 17 条
  • [1] A case of rhabdomyolysis in which levetiracetam was suspected as the cause
    Akiyama, Hisanao
    Haga, Yoshiteru
    Sasaki, Naoshi
    Yanagisawa, Toshiyuki
    Hasegawa, Yasuhiro
    [J]. EPILEPSY & BEHAVIOR CASE REPORTS, 2014, 2 : 152 - 155
  • [2] Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy
    Berkovic, S. F.
    Knowlton, R. C.
    Leroy, R. F.
    Schiemann, J.
    Falter, U.
    [J]. NEUROLOGY, 2007, 69 (18) : 1751 - 1760
  • [3] Levetiracetam for partial seizures - Results of a double-blind, randomized clinical trial
    Cereghino, JJ
    Biton, V
    Abou-Khalil, B
    Dreifuss, F
    Gauer, LJ
    Leppik, I
    [J]. NEUROLOGY, 2000, 55 (02) : 236 - 242
  • [4] Retrograde influence of muscle fibers on their innervation revealed by a novel marker for slow motoneurons
    Chakkalakal, Joe V.
    Nishimune, Hiroshi
    Ruas, Jorge L.
    Spiegelman, Bruce M.
    Sanes, Joshua R.
    [J]. DEVELOPMENT, 2010, 137 (20): : 3489 - 3499
  • [5] The syndrome of rhabdomyolysis: Complications and treatment
    Chatzizisis, Yiannis S.
    Misirli, Gesthimani
    Hatzitolios, Apostolos I.
    Giannoglou, George D.
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2008, 19 (08) : 568 - 574
  • [6] POSTICTAL ELEVATION OF SERUM CREATINE-KINASE LEVEL
    CHESSON, AL
    KASARSKIS, EJ
    SMALL, VW
    [J]. ARCHIVES OF NEUROLOGY, 1983, 40 (05) : 315 - 317
  • [7] THE SPECTRUM OF RHABDOMYOLYSIS
    GABOW, PA
    KAEHNY, WD
    KELLEHER, SP
    [J]. MEDICINE, 1982, 61 (03) : 141 - 152
  • [8] Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy
    Klitgaard, H
    Matagne, A
    Gobert, J
    Wülfert, E
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 353 (2-3) : 191 - 206
  • [9] Kubota K, 2017, NEUROL ASIA, V22, P275
  • [10] The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
    Lynch, BA
    Lambeng, N
    Nocka, K
    Kensel-Hammes, P
    Bajjalieh, SM
    Matagne, A
    Fuks, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (26) : 9861 - 9866